EQS-News: SARTORIUS AG / Key word (s): Quarter Results/Forecast Strong start to the year: Sartorius achieves significant profitable growth in the first quarter (news with additional features) 16.04 ...

German medical lab equipment maker Sartorius saw a jump in first-quarter net profit to €48.5 million ($55.2 million), up from ...

Investing.com -- S&P Global Ratings has downgraded the long-term issuer and issue credit ratings of Sartorius AG (ETR:SATG) from ’BBB’ to ’BBB-’ due to macroeconomic volatility and ...

DJ Sartorius Stedim Biotech publishes unaudited first quarter results for 2025 Sartorius Stedim Biotech SA / Key word(s): Quarter Results/Forecast Sartorius Stedim Biotech publishes unaudited ...

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell ...

Sartorius reported a strong jump in profitability, with underlying EBITDA rising 12.2% to 263 million euros in the first quarter. The EBITDA margin expanded to 29.8%. Order intake also came in ahead ...

Sartorius to acquire microtissue business MatTek from Swedish BICO AB (news with additional features) 04.04.2025 / 18:00 CET/CEST The issuer is solely responsible for the content of this ...

The convenient and reliable approach to achieve proper results. Depending on the user's samples, the Sartorius Application Laboratories based in the US and Germany will identify the individual ...

SEOUL, March 24 (Yonhap) -- Samsung E&A Co. said Monday it has secured a 518.6 billion-won (US$354.2 million) contract to build a biopharmaceutical raw material production and research facility in ...